Hoxworth Blood Center Welcomes New Chief Medical Officer
Hoxworth Blood Center is welcoming a new chief medical officer. David Oh, MD, assumes that role on Oct. 30, 2017, taking over for the recently retired Patricia Carey, MD.
Oh brings more than 15 years of experience in blood banking medical oversight to Hoxworth. For the past four years, Oh served as medical director at Stanford Blood Center in California. Prior to that, he served for nine years as the medical director of the San Diego Blood Bank and for two years as the associate medical director of the American Red Cross Blood Services in the Western Lake Erie Region.
"Dr. Ohs expertise will help us support and strengthen the services we provide to patients and donors in the Tri-State, says Ronald Sacher, MD, Hoxworth Blood Center director, and professor in the Department of Internal Medicine at the UC College of Medicine. "He brings many attributes to the senior leadership of Hoxworth and will play a key role in our clinical and strategic efforts going forward.
Oh, a Wisconsin native, graduated from the University of Wisconsin-Madison and received his medical degree from the University of Wisconsin School of Medicine. Following a five-year residency in anatomic and clinical pathology at the Cleveland Clinic, he completed a blood banking/transfusion medicine fellowship at the BloodCenter of Wisconsin/Medical College of Wisconsin.
Oh will have a faculty appointment as an associate professor in the Department of Pathology and Laboratory Medicine at the UC College of Medicine.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.